Compare iShares S&P GSCI Commodity-Indexed Trust ETF (GSG) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares S&P GSCI Commodity-Indexed Trust ETF vs Halozyme Therapeutics Inc. Common Stock — how do they compare? iShares S&P GSCI Commodity-Indexed Trust ETF trades at $36.08 (market cap $1.02B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 12.3× iShares S&P GSCI Commodity-Indexed Trust ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,256,221). Which is the better fit depends on your goals — on Pluang, investors hold iShares S&P GSCI Commodity-Indexed Trust ETF for 40 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| GSG | HALO | |
|---|---|---|
Market Cap | $1.02B | $12.58B |
Volume | 1,256,221 | 2,179,278 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $37.15 | $115.22 |
52-Week Low | $22.45 | $61.63 |
Typical Hold Time | 40 Days | 1 Days |
Enterprise Value | — | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares S&P GSCI Commodity-Indexed Trust ETF
GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
